WASHINGTON, DC: Pfizer CEO Albert Borla says his company is rapidly developing a pill to treat Covid 19 that will be available by the end of this year.
It should be noted that this will not be a vaccine but a coronavirus after the coronavirus has been attacked, the initial medical tests of which have been started in March this year.
To kill the corona virus, the drug reduces the production of an enzyme that helps the corona virus to divide and intensify its effects once it reaches the human cell.
If medical trials of this drug are successful and the US Food and Drug Administration (FDA) approves it in time, then it will be available throughout the United States by December 2021.
According to Pfizer, the drug will be given at the first sign of coronavirus infection, after which the patient will not need to be admitted to the hospital or face the ICU. On the contrary, by taking this medicine, he will gradually recover.
Experts hope that with the advent of this pill, the corona virus will become just as common a disease to humans as the common cold today.